D1 Capital Partners L.P. Charles River Laboratories International, Inc. Transaction History
D1 Capital Partners L.P.
- $4.55 Billion
- Q4 2024
A detailed history of D1 Capital Partners L.P. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, D1 Capital Partners L.P. holds 935,820 shares of CRL stock, worth $99.8 Million. This represents 3.8% of its overall portfolio holdings.
Number of Shares
935,820Holding current value
$99.8 Million% of portfolio
3.8%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
50MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$657 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$542 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$233 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$193 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$192 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.42B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...